MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Medtronic rises on Street-beating Q3

Medtronic rises on Street-beating Q3

By

Medtronic logo updatedMedtronic (NYSE:MDT) shares ticked up when the market opened today on third-quarter results that topped the consensus forecast.

The Fridley, Minn.-based medtech giant posted profits of $1.3 billion, or 94¢ per share, on sales of $7.8 billion for the three months ended Jan. 29, 2021, for a -33.4% bottom-line slide on sales growth of 0.8%.

Adjusted to exclude one-time items, earnings per share were $1.29, 14¢ ahead of  Wall Street, where analysts were looking for sales of $7.8 billion.

Medtronic saw a 4% revenue decrease in its cardiac and vascular group as a result of the resurgence of COVID-19 and the dip in procedure volumes, with the largest sub-segment decline for that group coming in the coronary and structural heart business (-7.9%).

However, the company’s other businesses all saw improvements in revenues, with minimally invasive therapies growing by 6.3% thanks to COVID-19-related diagnostics and therapeutics. The diabetes business rose 3.3% and the restorative therapies group at Medtronic ticked up 0.7%.

“Our Q3 results reflect that our business is well on the way to returning to growth, with sequential improvements in both revenue and earnings, despite the impact of the COVID resurgence on procedure volumes in late December and January. We’re outperforming our end markets, as new products are driving share gains in an increasing number of our businesses,” Medtronic chairman & CEO Geoff Martha said in a news release. “Looking ahead, we’re positioning ourselves for long-term success as we implement our new operating model and execute on a number of large opportunities to win share and create and disrupt big markets.”

Martha also announced during an earnings call today that the company is on track to file for a CE Mark and U.S. IDE approval next month for its new Hugo system that is meant to rival Intuitive Surgical’s da Vinci robots.

Medtronic said the near-term uncertainties caused by the COVID-19 pandemic mean it won’t be providing quarterly or full-year guidance at this time.

MDT shares were up 2.4% at $118.35 per share at market open today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down -0.6%.

In case you missed it

RSS From Medical Design & Outsourcing

  • 3D ‘lung-on-a-chip’ will test COVID-19 drugs
    Researchers in Boston have developed a novel technology to study the effects of COVID-19 on lung tissue, and to test treatments for it. The “3-D lung-on-a-chip” by Brigham & Women’s Hospital researchers models the distal lung and alveolar structures — the tiny air sacs that take in oxygen as you breathe. They are studying how… […]
  • FDA maps return to inspection normalcy
    The FDA has mapped out how it plans to catch up on pandemic-delayed facility inspections — including 2,426 medtech inspections. In a new report called Resiliency Roadmap for FDA Inspectional Oversight, the agency said it will prioritize inspections in terms of urgency and the threat posed by COVID-19 domestically and abroad. The FDA had planned… […]
  • Zimmer Biomet is looking to put sensors in more than just knee implants
    Even as Zimmer Biomet prepares to launch its Persona-IQ smart knee implant later this year, the ortho device giant is looking at additional opportunities to package sensors inside ortho implants. Startup Canary Medical (Vancouver, British Columbia), which created the Canary Health Implantable Reporting Processor (CHIRP) that is going inside the Persona-IQ, has cemented a long-term… […]
  • Protolabs meets on earnings, beats on revenue in Q1
    Protolabs (NYSE: PRLB) today met the Wall Street consensus on its Q1 earnings, surpassing analysts’ expectations when it came to revenue. The Maple Plain, Minn.–based digital manufacturer — which supports medtech and many other industries — reported profits of $3.7 million, or 13¢ per share — about a quarter of the profits that Protolabs saw… […]
  • Allied Motion releases motion control design guide for surgical robots
    Allied Motion Technologies (Amherst, N.Y.) has released a new guide to its custom motion control products for advanced medical robot applications. The guide highlights several motors, drives and control systems, and the uses of each for specific applications. Allied offers co-design and development, has ISO 13485-certified production facilities and a global supply chain . Specific… […]
  • Quasar Medical names new CEO
    Contract manufacturer Quasar Medical announced today that its board of directors has named Alex Wallstein as CEO. Ayal Amitai, CEO since July 2005, is stepping down and transitioning to executive director of the board and senior advisor to the CEO, as well as retaining his shareholdings in Quasar. Wallstein comes with many years of senior… […]
  • Wytech Industries names new president
    Specialty and precision wire manufacturer Wytech Industries (Rahway, N.J.) today announced it has named David Ohmann as president. Ohmann has nearly 25 years of experience in international, orthopedic and advanced surgical medical device segments. Prior to joining Wytech, Ohmann held sales and marketing leadership positions at Heraeus and MicroGroup (a TE Connectivity company). Ohmann has a… […]
  • Spectrum Plastics acquires Laser Light Technologies
    Spectrum Plastics Group has announced the acquisition of substantially all assets of Laser Light Technologies. An ISO 9001- and ISO 13485-certified organization based in Hermann, Mo., Laser Light Technologies provides custom laser processing systems and services using excimer, femtosecond, picosecond and YAG laser technologies. “The addition of the talented team at Laser Light Technologies brings… […]
  • Dymax announces deal with coatings company
    Dymax and nanocoatings manufacturer HZO today announced a strategic partnership. The deal will add 3,000 coatings formulations to HZO’s portfolio, facilitate joint product development, and use Dymax’s global sales channel to extend market reach. Dymax (Torrington, Conn.) manufactures rapid light-cure adhesives, conformal coatings, potting compounds and complementary dispensing and curing equipment used in medtech and… […]
  • Qosina releases 2022 catalog
    Qosina said today it has released the latest edition of its product catalog in both print and digital formats. The 2022 product catalog includes thousands of single-use medical and pharma components depicted in full-scale photos on a one-centimeter grid to help design engineers visualize their next-generation medical device, according to the Ronkonkoma, N,.Y.-based company. Qosina… […]
  • Medline completes $1.5B spending plan
    Medline Industries announced this week that it has completed a three-year, $1.5 billion capital spending campaign. The Northfield, Ill.-based company, which is reportedly up for sale, said it invested the money in new distribution centers, manufacturing capabilities and IT upgrades to improve customers’ e-commerce experience. All told, the initiative added approximately 8,500 new jobs, eight… […]